Tesamorelin TSM10 10mg*10vials

Tesamorelin TSM10 10mg x 10 Vials

Product Overview

Tesamorelin TSM10 is a high-concentration formulation in the TSM series of modified GHRH analog research peptides, representing a saturated upgrade of TSM2 and intermediate-potency TSM5. Utilizing structural optimization and full-molecule activity enhancement technologies, it retains Tesamorelin core advantages including anti-enzymatic degradation and dual-targeting of visceral-liver lipid metabolism, while supporting pathway binding affinity and endocrine activation intensity enhancement research. With a saturation concentration upper limit of 10mg, TSM10 supports comprehensive lipolysis efficacy and strong metabolic remodeling capability research, exceeding the efficacy range of low- and medium-dose TSM variants. Designed for high-dose gradient threshold studies, high-intensity visceral fat ablation research, severe fatty liver metabolic reversal studies, extreme insulin resistance intervention research, and high-standard complex peptide synergistic effect validation research, it serves as a core research material for high-end preclinical studies targeting refractory lipid metabolism disorders and advanced age-related lipodystrophy.

Core Research Functions

Saturated High-Amplitude Physiological Pulsatile GH Secretion and IGF-1 Peak Upregulation: Supports saturated high-amplitude physiological pulsatile growth hormone secretion research and sustained insulin-like growth factor-1 peak level upregulation studies, fully activating deep mitochondrial lipid oxidation and catabolism and systemic lipid transport pathway research.

Severe and Extreme Visceral Fat Breakdown and Liver Lipid Deposition Clearance: Supports severe and extreme visceral fat breakdown research, liver lipid deposition clearance studies, comprehensive lipid inflammation relief research, and high-threshold insulin sensitivity improvement research.

Severe Visceral Fat Accumulation and Advanced Fatty Liver Metabolic Disorder Intervention: Supports severe visceral fat accumulation reversal research, advanced fatty liver metabolic disorder intervention studies, and refractory lipid metabolism imbalance regulation research.

Anti-Aging Endocrine Repair and Lean Tissue Maintenance: Supports anti-aging endocrine repair research and high-density lean tissue maintenance effect studies.

Natural Physiological Rhythms Activation Adherence: Supports natural physiological rhythms activation adherence research, feedback inhibition and long-term receptor desensitization related studies, and stable endocrine homeostasis maintenance research under high-intensity long-term intervention.

Unlike the mild basal effect of TSM2 and the balanced moderate efficacy of TSM5, TSM10 reaches the upper limit in core research dimensions. TSM10 is suitable for metabolic mechanism research, extreme dose gradient screening, and high-quality peptide combination regimen validation, providing significant phenotypic differentiation and comprehensive reproducible data support for extreme intervention mechanism in-depth exploration targeting lipid metabolism and metabolic syndrome research.

Core Product Advantages

TSM10 Comprehensive Flagship Upgrade: The advanced specification of the TSM series, with optimized molecular structure and target activity. It inherits Tesamorelin unique lipid-targeting properties while supporting metabolic intervention intensity enhancement research, achieving advanced efficacy level among modified GHRH lipid-regulating peptides.

Visceral and Hepatic Lipid Clearance: Building upon the efficacy of intermediate doses, it further supports deep fat and liver pathway activation enhancement research, achieving stubborn visceral fat and severe hepatic lipid deposits clearance research. It provides research capabilities for mild to moderate metabolic disorder improvement that exceed low- and intermediate-dose version ranges.

Stable Modified Molecular System: Mature enhanced structural modifications support anti-degradation and anti-metabolic stability research, supporting long-term high-intensity chronic metabolic intervention research. It outputs sustainable stable lipid regulation signals, supporting hormonal fluctuations and endocrine interference related studies, ensuring stable long-term modeling data research capabilities.

10mg Saturation Upper Limit Specification: Advanced flagship concentration, twice the potency of TSM5 and five times that of TSM2. Suitable for high-dose extreme gradient experiments, refractory metabolic disorder intervention research, and high-standard complex peptide synergistic studies, covering high-threshold research scenarios that exceed low- and medium-dose version support ranges.

Pharmaceutical-Grade Quality Assurance: Employs advanced aseptic vacuum freeze-drying technology to support peptide peak intrinsic activity stable retention research. Each batch undergoes comprehensive HPLC high-purity testing and is accompanied by a complete Certificate of Analysis (COA). Standard 10-vial aseptic integrated packaging meets the needs of advanced laboratory research, key metabolic science projects, drug preclinical development, and bulk wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 10mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).